1 study found for:    nct00752206
Show Display Options
Rank Status Study
1 Recruiting A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
Condition: Osteosarcoma
Interventions: Drug: Saracatinib;   Drug: Placebo

Indicates status has not been verified in more than two years